Life insurance products have been more complicated and now include specified disease (e.g., critical illness and cancer) coverage as a policy or a rider. The information needed to develop and market these products can be limited. There are common elements and considerations that should be considered as an organization decides on whether, when and how to price and market these products. We will also share lessons learned from similar products sold outside the U.S. Attend this session to learn more about these considerations and the differences in pricing practices in developing specified disease riders or policies.
-
1.80 SOA CPD
1.50 CIA
-
Presented By:
Smaller Insurance Company Section
